These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma. Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116 [TBL] [Abstract][Full Text] [Related]
43. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539 [TBL] [Abstract][Full Text] [Related]
44. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218 [TBL] [Abstract][Full Text] [Related]
45. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179 [TBL] [Abstract][Full Text] [Related]
46. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA. Bernstein D; Andersen L; Forth R; Jacques L; Yates L J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020 [TBL] [Abstract][Full Text] [Related]
47. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial. Lin J; Kang J; Lee SH; Wang C; Zhou X; Crawford J; Jacques L; Stone S Respir Med; 2015 Jan; 109(1):44-53. PubMed ID: 25524507 [TBL] [Abstract][Full Text] [Related]
48. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049 [TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327 [TBL] [Abstract][Full Text] [Related]
50. Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. Woodcock A; Bateman ED; Busse WW; Lötvall J; Snowise NG; Forth R; Jacques L; Haumann B; Bleecker ER Respir Res; 2011 Oct; 12(1):132. PubMed ID: 21977941 [TBL] [Abstract][Full Text] [Related]
51. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids. Chuchalin A; Jacques L; Frith L Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402 [TBL] [Abstract][Full Text] [Related]
52. The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study. Lee LA; Yang S; Kerwin E; Trivedi R; Edwards LD; Pascoe S Respir Med; 2015 Jan; 109(1):54-62. PubMed ID: 25452139 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ Respir Med; 2014 Aug; 108(8):1171-9. PubMed ID: 24998880 [TBL] [Abstract][Full Text] [Related]
54. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety. Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D; Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178 [TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892 [TBL] [Abstract][Full Text] [Related]
57. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids. Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150 [TBL] [Abstract][Full Text] [Related]
58. Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial. Bleecker ER; Lötvall J; O'Byrne PM; Woodcock A; Busse WW; Kerwin EM; Forth R; Medley HV; Nunn C; Jacques L; Bateman ED J Allergy Clin Immunol Pract; 2014; 2(5):553-61. PubMed ID: 25213048 [TBL] [Abstract][Full Text] [Related]
59. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review. Muley P; Shah M; Muley A Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431 [TBL] [Abstract][Full Text] [Related]